Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies

Bone Marrow Transplantation

Volumn 49, Issue 5, 2014, Pages 634-639

  Konuma, T ^a   Kato, S ^a   Ooi, J ^b   Oiwa Monna, M ^a   Ebihara, Y ^a   Mochizuki, S ^a   Yuji, K ^a   Ohno, N ^a   Kawamata, T ^a   Jo, N ^a   Yokoyama, K ^a   Uchimaru, K ^a   Tojo, A ^a   Takahashi, S ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cord blood transplantation; graft versus host disease; H Y antigens; minor histocompatibility antigens; sex incompatibility

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOCOMPATIBILITY; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX INCOMPATIBILITY; THROMBOCYTE; TREATMENT OUTCOME; ALLOTRANSPLANTATION; B LYMPHOCYTE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; SEX RATIO; T LYMPHOCYTE; Y CHROMOSOME; YOUNG ADULT;

MINOR HISTOCOMPATIBILITY ANTIGEN;

ADOLESCENT; ADULT; B-LYMPHOCYTES; CHROMOSOMES, HUMAN, Y; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HUMANS; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84900300877     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.10     Document Type: Article

References (38)

1. Warren EH, Zhang XC, Li S, Fan W, Storer BE, Chien JW et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood 2012; 120: 2796-2806
2. Gahrton G. Risk assessment in haematopoietic stem cell transplantation: Impact of donor-recipient sex combination in allogeneic transplantation. Best Pract Res Clin Haematol 2007; 20: 219-229
3. Gratwohl A, Hermans J, Niederwieser D, Van Biezen A, Van Houwelingen HC, Apperley J. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2001; 2: 363-370
4. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103: 347-352
5. Gahrton G, Iacobelli S, Apperley J, Bandini G, Björkstrand B, Bladé J et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: Reduced relapse risk in female to male transplants. Bone Marrow Transplant 2005; 35: 609-617
6. Gallardo D, Perez-García A, De La Cámara R, Iriondo A, Jimenez-Velasco A, Torres A et al. Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: Influence of stem cell source. Leukemia 2006; 20: 1461-1464
7. Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 758-769
8. Stern M, Passweg JR, Locasciulli A, Socié G, Schrezenmeier H, Békássy AN et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation 2006; 82: 218-226
9. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013; 122: 491-498
10. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: A retrospective analysis. Lancet Oncol 2010; 11: 653-660
11. Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2009; 113: 1631-1638
12. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322-1330
13. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al. Singleinstitute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813-3820
14. Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S et al. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica 2013; 98: 814-822
15. Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y et al. Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Biol Blood Marrow Transplant 2013; 19: 247-254
16. Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: A retrospective analysis. Lancet Oncol 2011; 12: 1214-1221
17. Stevens CE, Carrier C, Carpenter C, Sung D, Scaradavou A. HLA mismatch direction in cord blood transplantation: Impact on outcome and implications for cord blood unit selection. Blood 2011; 118: 3969-3978
18. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 2010; 115: 1843-1849
19. Matsuno N, Wake A, Uchida N, Ishiwata K, Araoka H, Takagi S et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 2009; 114: 1689-1695
20. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304
21. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217
22. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695-706
23. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
24. Kanda Y. Investigation of the freely-Available easy-to-use software 'EZR' (Easy R) for medical statistics. Bone Marrow Transplant 2013; 48: 452-458
25. Stern M, Brand R, De Witte T, Sureda A, Rocha V, Passweg J et al. Female-versusmale alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant 2008; 8: 2149-2157
26. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW et al. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 2004; 32: 397-407
27. Arcese W, Rocha V, Labopin M, Sanz G, Iori AP, De Lima M et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006; 91: 223-230
28. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381
29. Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: A pooled analysis of three international registries. Bone Marrow Transplant 2011; 46: 70-76
30. Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214-3219
31. Newell LF, Flowers ME, Gooley TA, Milano F, Carpenter PA, Martin PJ et al. Characteristics of chronic GVHD after cord blood transplantation. Bone Marrow Transplant 2013; 48: 1285-1290
32. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graftversus- leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562
33. Dierselhuis M, Goulmy E. The relevance of minor histocompatibility antigens in solid organ transplantation. Curr Opin Organ Transplant 2009; 14: 419-425
34. Gratwohl A, Döhler B, Stern M, Opelz G. H-Y as a minor histocompatibility antigen in kidney transplantation: A retrospective cohort study. Lancet 2008; 372: 49-53
35. Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Sci 2007; 98: 1139-1146
36. Feng X, Hui KM, Younes HM, Brickner AG. Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses. Trends Immunol 2008; 29: 624-632
37. Sahaf B, Yang Y, Arai S, Herzenberg LA, Herzenberg LA, Miklos DB. H-Y antigenbinding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs host disease. Proc Natl Acad Sci USA 2013; 110: 3005-3010
38. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005; 105: 2973-2978.